215 related articles for article (PubMed ID: 7030538)
1. Serum and blister fluid immune complexes in bullous pemphigoid: detection with C1q and monoclonal rheumatoid factor.
Jordon RE; Struve MF; Bushkell LL
Clin Exp Immunol; 1981 Jul; 45(1):29-36. PubMed ID: 7030538
[TBL] [Abstract][Full Text] [Related]
2. Immune complexes in pemphigus and bullous pemphigoid.
Ahmed AR; Moy RL; Chia D; Barnett EV
Dermatologica; 1983; 166(4):175-80. PubMed ID: 6343146
[TBL] [Abstract][Full Text] [Related]
3. Serum and blister fluid anticomplementary activity in pemphigus and bullous pemphigoid. Sucrose density gradient studies.
Jordon RE; McDuffie FC
Proc Soc Exp Biol Med; 1976 Mar; 151(3):594-8. PubMed ID: 768993
[TBL] [Abstract][Full Text] [Related]
4. Bullous pemphigoid: a correlative study of autoantibodies, circulating immune complexes and dermo-epidermal deposits.
Gomes MA; Dambuyant C; Thivolet J; Bussy R
Br J Dermatol; 1982 Jul; 107(1):43-51. PubMed ID: 6809029
[TBL] [Abstract][Full Text] [Related]
5. C1q binding substances in pemphigus and bullous pemphigoid. Detection with a [131I] C1q binding assay.
Tappeiner G; Heine KG; Kahl JC; Jordon RE
Clin Exp Immunol; 1977 Apr; 28(1):40-8. PubMed ID: 324678
[TBL] [Abstract][Full Text] [Related]
6. Localized bullous pemphigoid with negative immunofluorescence.
Silber JG; Brody N
Cutis; 1981 Nov; 28(5):562, 565. PubMed ID: 7030649
[TBL] [Abstract][Full Text] [Related]
7. Functional evidence for complement-activating immune complexes in the skin of patients with bullous pemphigoid.
Gammon WR; Merritt CC; Lewis DM; Sams WM; Wheeler CE; Carlo JR
J Invest Dermatol; 1982 Jan; 78(1):52-7. PubMed ID: 7033396
[TBL] [Abstract][Full Text] [Related]
8. Dermatitis herpetiformis: immune complex detection with C1q and monoclonal rheumatoid factor.
Jordon RE; Tappeiner G; Kahl JC; Wolff K
Br J Dermatol; 1981 Aug; 105(2):159-65. PubMed ID: 7025879
[TBL] [Abstract][Full Text] [Related]
9. The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody.
Jordon RE; Nordby JM; Milstein H
J Lab Clin Med; 1975 Nov; 86(5):733-40. PubMed ID: 1102620
[TBL] [Abstract][Full Text] [Related]
10. Lymphotoxin detected in the blister fluid of bullous pemphigoid patients.
Jeffes EW; Yamamoto RS; Ahmed AR; Granger GA
J Clin Immunol; 1984 Jan; 4(1):31-5. PubMed ID: 6365950
[TBL] [Abstract][Full Text] [Related]
11. Differences in complement-dependent chemotactic activity generated by bullous pemphigoid and epidermolysis bullosa acquisita immune complexes: demonstration by leukocytic attachment and organ culture methods.
Gammon WR; Inman AO; Wheeler CE
J Invest Dermatol; 1984 Jul; 83(1):57-61. PubMed ID: 6376640
[TBL] [Abstract][Full Text] [Related]
12. Ultrastructural localization of in vitro binding sites of circulating anti-basement membrane zone antibodies in bullous pemphigoid.
Yamasaki Y; Nishikawa T
Acta Derm Venereol; 1983; 63(6):501-6. PubMed ID: 6198839
[TBL] [Abstract][Full Text] [Related]
13. Pemphigoid antibody mediated attachment of peripheral blood leukocytes at the dermal-epidermal junction of human skin.
Gammon WR; Lewis DM; Carlo JR; Sams WM; Wheeler CE
J Invest Dermatol; 1980 Oct; 75(4):334-9. PubMed ID: 7000926
[TBL] [Abstract][Full Text] [Related]
14. C1q-latex assay for immune complexes. Complexes that react with both C1q and monoclonal rheumatoid factor in lupus erythematosus and lung cancer.
Medof ME
J Lab Clin Med; 1982 May; 99(5):678-92. PubMed ID: 6978370
[TBL] [Abstract][Full Text] [Related]
15. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
J Clin Lab Immunol; 1984 Oct; 15(2):63-8. PubMed ID: 6335179
[TBL] [Abstract][Full Text] [Related]
16. The complement system in bullous pemphigoid. I. Complement and component levels in sera and blister fluids.
Jordon RE; Day NK; Sams WM; Good RA
J Clin Invest; 1973 May; 52(5):1207-14. PubMed ID: 4573354
[TBL] [Abstract][Full Text] [Related]
17. Potential role of interleukin-17 in the pathogenesis of bullous pemphigoid.
Toosi S; Bystryn JC
Med Hypotheses; 2010 Apr; 74(4):727-8. PubMed ID: 19945799
[TBL] [Abstract][Full Text] [Related]
18. Detection of circulating immune complexes in cutaneous disease using a monoclonal rheumatoid factor hemagglutination method.
Jordon RE; Mackel SE; Brumfield H
J Clin Lab Immunol; 1981 Jul; 6(1):87-90. PubMed ID: 6790707
[TBL] [Abstract][Full Text] [Related]
19. Increased tryptase and myeloperoxidase levels in blister fluids of patients with bullous pemphigoid: correlations with cytokines, adhesion molecules and anti-basement membrane zone antibodies.
D'Auria L; Pietravalle M; Cordiali-Fei P; Ameglio F
Exp Dermatol; 2000 Apr; 9(2):131-7. PubMed ID: 10772387
[TBL] [Abstract][Full Text] [Related]
20. An in vitro model of immune complex-mediated basement membrane zone separation caused by pemphigoid antibodies, leukocytes, and complement.
Gammon WR; Merritt CC; Lewis DM; Sams WM; Carlo JR; Wheeler CE
J Invest Dermatol; 1982 Apr; 78(4):285-90. PubMed ID: 7040558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
